IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q4 2019 Holdings

Filed 2020-02-14 | 18 holdings | $6.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aldeyra Therapeutics Inc(ALDX)COM01438T106$3.3M569,40553.4%
Anavex Life Sciences Corp(AVXL)COM NEW032797300$1.9M724,20530.3%
Corteva Inc(CTVA)COM22052L104$887.0K30,00014.3%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$46.6K857,4940.8%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$27.6K5,045,8700.4%
Applied Therapeutics Inc(APLT)COM03828A101$12.7K467,0710.2%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$9.4K2,859,7670.2%
Blackstone Group LP(BXUSD)COM UNIT LTD09253U108$8.5K153,0000.1%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$5.2K350,2380.1%
Exicure Inc(XCUR)COM30205M101$3.7K1,277,7770.1%
Entera Bio Ltd(ENTX)SHSM40527109$3.6K1,741,3630.1%
Kraneshares TR(KBA)BOSERA MSCI CH500767405$3.1K96,0000.1%
Centurylink Inc(CTLEUR)COM156700106$2.9K220,0000.0%
Dow Inc(DOW)COM260557103$1.6K30,0000.0%
Molecular TemplatesCOM608550109$1.6K113,9050.0%
Soligenix Inc.COM834223307$1.1K787,8300.0%
Dupont de Nemours Inc(DD)COM26614N102$96315,0000.0%
Catasys IncCOM PAR149049504$70243,0340.0%